--- title: "SSY Group (2005) stock listing, news and investor profile" url: "https://aibio.space/companies/ssy/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "SSY Group Limited (HKEX: 2005), Hong Kong. The directory classifies it as Pharmaceuticals: Major." --- 2005 SSY Group Limited HKEX · Hong Kong # SSY Group (2005) news SSY Group Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2005, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest SSY Group news We have not published a story on SSY Group yet. When there is news, it will appear here. ## SSY Group at a glance - **Ticker**: 2005 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) HKEX: 8037 - [China Traditional Chinese Medicine Holdings Co.](https://aibio.space/companies/china-traditional-chinese-medicine/) HKEX: 570 - [Pak Fah Yeow International](https://aibio.space/companies/pak-fah-yeow-international/) HKEX: 239 - [Dawnrays Pharmaceutical Holdings](https://aibio.space/companies/dawnrays-pharmaceutical/) HKEX: 2348 - [Sanai Health Industry Group Company](https://aibio.space/companies/sanai-health-industry/) HKEX: 1889 - [Regencell Bioscience Holdings](https://aibio.space/companies/regencell-bioscience/) NASDAQ: RGC - [Extrawell Pharmaceutical Holdings](https://aibio.space/companies/extrawell-pharmaceutical/) HKEX: 858 - [China Regenerative Medicine International](https://aibio.space/companies/china-regenerative-medicine-international/) HKEX: 8158 ### Also on HKEX - [CARsgen Therapeutics Holdings](https://aibio.space/companies/carsgen-therapeutics/) 2171 - [CANbridge Pharmaceuticals](https://aibio.space/companies/canbridge-pharmaceuticals/) 1228 - [BioDlink International Company](https://aibio.space/companies/biodlink-international/) 1875 - [CF PharmTech](https://aibio.space/companies/cf-pharmtech/) 2652 - [CK Life Sciences International (Holdings)](https://aibio.space/companies/ck-life-sciences-international/) 775 - [AIM Vaccine Co.](https://aibio.space/companies/aim-vaccine/) 6660 ## Questions about SSY Group What is the ticker symbol of SSY Group? SSY Group Limited trades under the ticker 2005 on HKEX. Where is SSY Group listed? SSY Group Limited is listed on HKEX. Which country or territory is SSY Group listed under? Our directory records SSY Group Limited under Hong Kong. What does SSY Group do? Our directory classifies SSY Group Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of SSY Group? The ISIN recorded for SSY Group Limited is KYG8406X1034. Does aibio.space cover SSY Group? aibio.space lists SSY Group Limited among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to SSY Group? Companies in our directory listed in the same country and business area as SSY Group: China Biotech Services Holdings, China Traditional Chinese Medicine Holdings Co., Pak Fah Yeow International, Dawnrays Pharmaceutical Holdings, Sanai Health Industry Group Company, Regencell Bioscience Holdings. ## Investor discussion: SSY Group Members talk about SSY Group (2005). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at SSY Group, newest first. Each line links the filing it comes from. 1. 2026-04-21 Financings Share or debt issue: PROPOSALS FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF RETIRING DIRECTORS (3) DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100448.pdf) 2. 2025-04-16 Financings Share or debt issue: PROPOSALS FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF RETIRING DIRECTORS (3) DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0416/2025041600513.pdf) ## Press releases Headlines of SSY Group's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-26 HKEXnews [VOLUNTARY ANNOUNCEMENT - UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1026/2026102600254.pdf) 2. 2026-10-22 HKEXnews [VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1022/2026102200198.pdf) 3. 2026-09-28 HKEXnews [CHANGE OF EXECUTIVE DIRECTORS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0928/2026092801561.pdf) 4. 2026-09-14 HKEXnews [Notification Letter and Reply Form to Non-registered Shareholders - Notice of Publication of 2026 Interim Report](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0914/2026091400512.pdf) 5. 2026-09-14 HKEXnews [Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of 2026 Interim Report](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0914/2026091400506.pdf) 6. 2026-09-03 HKEXnews [VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON OPEN MARKET PURSUANT TO RESTRICTED SHARE AWARD SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0903/2026090301168.pdf) 7. 2026-08-26 HKEXnews [Interim Dividend for the six months ended 30 June 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600205.pdf) 8. 2026-08-26 HKEXnews [ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600191.pdf) 9. 2026-08-03 HKEXnews [VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0803/2026080303022.pdf) 10. 2026-07-10 HKEXnews [VOLUNTARY ANNOUNCEMENT - 95 TYPES OF PRODUCTS INCLUDED IN NATIONAL ESSENTIAL MEDICINES LIST (2026 EDITION)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0710/2026071000137.pdf) 11. 2026-06-14 HKEXnews [VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE - LETTER OF INTENT IN RELATION TO THE LICENSE OF CLASS 1 INNOVATIVE DRUG OPT101](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0615/2026061500083.pdf) 12. 2026-06-05 HKEXnews [BUSINESS UPDATE - LETTER OF INTENT IN RELATION TO FOUR BIOSIMILAR DRUGS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500259.pdf) 13. 2026-06-04 HKEXnews [BUSINESS UPDATE - LETTER OF INTENT IN RELATION TO TWO CLASS 2 MODIFIED NEW DRUGS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0604/2026060402535.pdf) 14. 2026-05-15 HKEXnews [POLL RESULTS OF ANNUAL GENERAL MEETING 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0515/2026051500424.pdf) 15. 2026-05-04 HKEXnews [VOLUNTARY ANNOUNCEMENT - UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0504/2026050401367.pdf) 16. 2026-04-21 HKEXnews [Notification Letter and Reply Form to Non-registered Shareholders - Notice of Publication of 2025 Annual Report and Circular](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100502.pdf) 17. 2026-04-21 HKEXnews [Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of 2025 Annual Report, Circular and Proxy Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100490.pdf) 18. 2026-04-21 HKEXnews [Notice of Annual General Meeting](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100464.pdf) 19. 2026-04-21 HKEXnews [PROPOSALS FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF RETIRING DIRECTORS (3) DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100448.pdf) 20. 2026-03-27 HKEXnews [Final Dividend for the year ended 31 December 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0327/2026032700401.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2005 on TradingView](https://www.tradingview.com/symbols/HKEX-2005/). ## Listing details SSY Group Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2005, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: SSY Group Limited - **Ticker**: 2005 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG8406X1034 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2005/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/ssy/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "SSY Group (2005) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/ssy/